Business Wire

Water Leaders to Accelerate Action Towards UN Sustainable Development Goals at IWA World Water Congress 2022

12.9.2022 12:00:00 EEST | Business Wire | Press release

Share

There are 2.3 billion people who now live in water-stressed countries and 18 million people risk being displaced by floods every year1. Against this backdrop, global water technology company Xylem (NYSE: XYL), will join water sector leaders at the IWA World Water Congress & Exhibition, to explore solutions to build water security. Xylem executives will share perspectives on actions to increase communities’ resilience to water scarcity, and strategies to accelerate the decarbonization of water networks.

The congress takes place in Copenhagen, Denmark, 11-15 September 2022. On Wednesday, September 14, Dave Flinton, Xylem’s Chief Innovation, Technology and Product Management Officer, will discuss the business models and multidisciplinary approaches needed for successful innovation in resource recovery. Learning to Dance in the Rain — How to Thrive in an Era of Climate Change, will explore actions taken to date and future trends.

Commenting on the congress, Dave Flinton said, “Technology can make communities more resilient in the face of severe weather. Through innovation and collaboration, we can modernize water systems so that communities have affordable, accessible water, and are buffered from shocks like droughts and floods.”

On Monday, September 12, Austin Alexander, Vice President, Sustainability and Social Impact at Xylem, will take part in a keynote plenary discussion – Practical Perspectives in Building Resilience into Urban Water Management. During the session, she will share insights on building urban resiliency in the face of climate change, the solutions that are available, and the importance of maintaining momentum on the UN SDGs. As water infrastructure is a contributor to greenhouse gas (GHG) emissions, Alexander will also touch on the use of technology to meaningfully reduce emissions and help transform the future of water management.

On Wednesday, September 14, Xylem’s Global Procurement Sustainability Manager, Andrea Montuori will participate in a keynote plenary session on Uniting Youth for Water. This session will examine the role of youth within the water sector, with a special focus on the UN 2023 Water Conference, taking place in March next year.

Xylem will also hold two business forums at the congress:

  • On Tuesday, September 13, Joost Aloserij, Director of Business Development, Central & North Europe at Xylem, will lead a forum on Let's Redefine what's Possible for Water. Drawing on Xylem Vue, Xylem’s digital solutions platform that combines smart, connected technologies with intelligent systems and services. This session will focus on how utilities can embrace digital innovation to improve performance, reduce costs, and better serve their communities.
  • On Wednesday, September 14, Alexis De Kerchove, Senior Director, Marketing and Business Development, Europe Commercial Team, will lead a forum on Road to Net Zero, alongside Austin Alexander. This session will explore the importance of decarbonization for water and wastewater utilities.

Xylem is also the proud sponsor of the IWA Climate Smart Utilities Recognition Program which aims to inspire utilities and all their stakeholders to become Climate Smart and embrace climate resilience under three key pillars for action – adaptation, mitigation, and leadership. Following a robust review, forty-two Climate Smart utilities will be honored at the IWA World Water Congress & Exhibition closing ceremony on Thursday, September 15.

About Xylem

Xylem (XYL) is a leading global water technology company committed to solving critical water and infrastructure challenges with innovation. Our 17,000 diverse employees delivered revenue of $5.2 billion in 2021. We are creating a more sustainable world by enabling our customers to optimize water and resource management and helping communities in more than 150 countries become water secure. Join us at www.xylem.com.

______________________
1 https://www.internal-displacement.org/global-report/grid2019/

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Houston Spencer
+1 (914) 240-3046
Houston.Spencer@xylem.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Askey and Canoga Perkins Announce Strategic Collaboration at MWC Barcelona to Deliver Rapid-Deploy 5G Critical Communications Solutions27.3.2026 13:00:00 EET | Press release

Askeyand Canoga Perkinsannounced at Mobile World Congress Barcelona a Global Partnership to Deliver SyncMetra® Network Connectivity Solution, combining Canoga Perkins’ software-defined, IT-operated private 5G network transport along with Askey’s carrier-grade 5G radio access technology. At MWC Barcelona 2026, Askey Computer Corporation and Canoga Perkins announced a strategic partnership to deploy Canoga Perkins' SyncMetra® Platform across enterprise and service provider markets with Askey. This partnership pairs Askey’s carrier-grade radio access capabilities with Canoga Perkins’ industry-leading time-sensitive networking (TSN) and synchronization technology, enabling customers to simplify deployment of ultra-low-latency, highly reliable network services for 5G, edge compute, industrial automation, and mission-critical enterprise applications. The partnership enables joint go-to-market efforts, integrated product offerings, and expanded access to SyncMetra through Askey’s sales channe

SBC Medical Announces Fourth Quarter and Full Year 2025 Financial Results27.3.2026 12:40:00 EET | Press release

SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a Management Services Organization operating a wide range of franchise businesses across diverse medical fields, today announced its financial results for the fourth quarter of fiscal year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve months ended December 31, 2025). Fourth Quarter 2025 Highlights Total revenues were $40 million, representing an 11% year-over-year decrease. Net Income attributable to SBC Medical Group was $14 million, representing a 117% year-over-year increase. Earnings per share, which is defined as net income attributable to the Company divided by the weighted average number of outstanding shares, was $0.14 for the three months ended December 31, 2025, representing 133% year-over-year increase. EBITDA1, which is calculated by adding depreciation and amortization expense and impairment loss on intangible assets to income from operations was

NIQ Redefines Packaging Intelligence with Monthly, Harmonized Global Performance Visibility27.3.2026 12:00:00 EET | Press release

NielsenIQ (NYSE: NIQ), a global leader in consumer intelligence, today announced the launch of its Packaging Strategic Planner Global (SPG) Solution, the first harmonized global platform to deliver monthly visibility into packaging performance across materials, formats, and pack configurations. As packaging innovation accelerates, many organizations continue to rely on fragmented or annual data to inform packaging decisions. The Packaging SPG Solution closes this gap by providing real-time data delivered monthly across regions, enabling brands and packaging partners to uncover trends, grow revenue, and strengthen relationships with CPG and retail partners. Key Highlights: New monthly global packaging tracking capability Coverage across 200+ categories Visibility into 30+ package types and 20 package materials 10+ markets at launch, expanding to 30 by the end of 2026 Introduction of NIQ’s exclusive EQ2 metric, multiplying units by number in pack to reflect true consumption “The pace of

European DataWarehouse Claims Its First “Fintech Provider of the Year” Award and a Sixth “Data Provider of the Year” Title at GlobalCapital’s 2026 European Securitisation Awards27.3.2026 09:47:00 EET | Press release

European DataWarehouse (EDW) is pleased to announce that it has been named both “Data Provider of the Year” and “Fintech Provider of the Year” at the 2026 GlobalCapital European Securitization Awards in London. The award ceremony recognises outstanding achievements in European structured finance, with winners selected by popular vote from across the industry. As defined by GlobalCapital, the programme celebrates “the very best in the market, as chosen by the market.” This latest recognition marks the sixth time that EDW has received the prestigious Data Provider of the Year award, having previously been honoured in 2019, 2022, 2023, 2024 and 2025, reaffirming its long-standing commitment to transparency, data quality and innovation in European securitisation. Prof. José Manuel González-Páramo, Chairman of EDW, later commented: “ Winning this award for the sixth time highlights the continued trust the European securitisation market places in EDW. Transparency, data quality and reliabili

Biocytogen Announces FDA IND Clearance for Partner NEOK Bio’s NEOK002 Targeting Solid Tumors27.3.2026 02:00:00 EET | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its partner NEOK Bio, Inc. recently received clearance from the U.S. Food and Drug Administration (FDA) of an investigational new drug (IND) application for NEOK002, an EGFR/MUC1-targeting ADC program for solid tumors. NEOK Bio plans to initiate a Phase 1 clinical study in the second quarter of 2026 and expects to report initial data in 2027. This IND clearance marks an important milestone for NEOK002, an EGFR/MUC1-targeting ADC candidate developed by NEOK Bio and built on a bispecific antibody originally developed by Biocytogen and licensed in 2024. According to NEOK Bio, NEOK002 is being advanced for solid tumors and may offer differentiated efficacy and safety compared with monospecific ADC approaches directed at either target alone. Dr. Yuelei Sh

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye